The cutbacks would have “minimal impact,” the government said, but economists warned of reduced confidence in inflation data produced by a struggling statistical system.
Category: Commerce Department
-
Nvidia’s Chief Says U.S. Chip Controls on China Have Backfired
Jensen Huang, the chipmaker’s top executive, said the attempt to cut off the flow of advanced A.I. chips spurred Chinese companies to “accelerate their development.”
-
Trump Administration Considers Large Chip Sale to Emirati A.I. Firm G42
The firm, which the U.S. government scrutinized for its ties to China, is angling for hundreds of thousands of advanced artificial intelligence chips in a deal that could be finalized this week.
-
U.S. Starts Investigation Into Imported Planes and Parts
The Trump administration could use the investigation to impose new tariffs on imported planes, jet engines and other aerospace parts.
-
For the U.S. and China, the Only Talking Is About Whether to Talk
The standoff over terms of negotiations, and whether they are happening, signals that a protracted economic fight lies ahead.
-
U.S. Economy Shrank in First Quarter as Trump Tariffs Loomed
Underlying economic growth remained solid in early 2025, but tariffs and uncertainty are expected to cause a further slowdown.
-
Trump Administration Looks to Take Steps to Ease Pain From Car Tariffs
The planned concessions to give automakers more time to relocate production to the United States would still leave substantial tariffs on imported cars and car parts.
-
Howard Lutnick, Trump’s ‘Buoyant’ Trade Warrior, Flexes His Power Over Global Business
Howard Lutnick, the secretary of commerce, has become a go-to for major companies seeking relief from tariffs. But he’s not always friendly to their interests.
-
Peter Navarro: The Architect of Trump’s Tariffs
Once sidelined, President Trump’s counselor Peter Navarro has returned to Washington and quickly upended the global trading system.
-
Trump’s Tariff Threat for Drug imports Poses Big Political Risks
Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
